國芯科技(688262.SH):CCFC3008PT芯片可以用作智能座艙的功能安全芯片
格隆匯8月2日丨有投資者向國芯科技(688262.SH)提問,“國芯科技的域控制bms控制器CCFC3008PT是對標英飛凌的Tc397,英飛凌的397在高通的自動駕駛ride3.0平台,智能座艙都有用,請問國芯科技這款未來有希望搭配國內的自動駕駛平台,智能座艙嗎?”
國芯科技回覆稱,公司CCFC3008PT芯片主要應用領域為汽車動力總成、線控底盤控制、動力電池控制器和高性能高集成度的域控制器,可以用作智能座艙的功能安全芯片。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.